0000950170-24-028044.txt : 20240307 0000950170-24-028044.hdr.sgml : 20240307 20240307163154 ACCESSION NUMBER: 0000950170-24-028044 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 13 CONFORMED PERIOD OF REPORT: 20240307 ITEM INFORMATION: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing ITEM INFORMATION: Other Events ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20240307 DATE AS OF CHANGE: 20240307 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Cyteir Therapeutics, Inc. CENTRAL INDEX KEY: 0001662244 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 455429901 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-40499 FILM NUMBER: 24730637 BUSINESS ADDRESS: STREET 1: P.O. BOX 80084 CITY: STONEHAM STATE: MA ZIP: 02180 BUSINESS PHONE: 857-285-4140 MAIL ADDRESS: STREET 1: P.O. BOX 80084 CITY: STONEHAM STATE: MA ZIP: 02180 8-K 1 cyt-20240307.htm 8-K 8-K
0001662244false00016622442024-03-072024-03-07

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): March 7, 2024

 

 

Cyteir Therapeutics, Inc.

(Exact name of Registrant as Specified in Its Charter)

 

 

Delaware

001-40499

45-5429901

(State or Other Jurisdiction
of Incorporation)

(Commission File Number)

(IRS Employer
Identification No.)

 

 

 

 

 

P.O. Box 80084

 

Stoneham, Massachusetts

 

02180

(Address of Principal Executive Offices)

 

(Zip Code)

 

Registrant’s Telephone Number, Including Area Code: 857 285-4140

 

Not Applicable

(Former Name or Former Address, if Changed Since Last Report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:


Title of each class

 

Trading
Symbol(s)

 


Name of each exchange on which registered

Common Stock, $0.001 par value per share

 

CYT

 

The Nasdaq Global Select Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

 

 

Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

 

On March 7, 2024, Cyteir Therapeutics, Inc. (the “Company”) delivered formal notice to The Nasdaq Stock Market that the Company intends to voluntarily delist its common stock, par value $0.001 per share (the “Common Stock”), from the Nasdaq Global Select Market (“Nasdaq”) in connection with the Company’s voluntary Plan of Complete Liquidation and Dissolution previously approved by the Company’s Board of Directors and stockholders.

 

The Company expects to file a Notification of Removal from Listing and/or Registration on Form 25 with the Securities and Exchange Commission (the “SEC”) on or about March 18, 2024 to effect the voluntary delisting of the Common Stock under Section 12(b) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and that the delisting will be effective on or about March 28, 2024, ten days after the filing of the Form 25. In connection with the foregoing, the Company requested that the trading of the Common Stock on Nasdaq be suspended effective before the market opens on March 18, 2024. Following the effectiveness of the delisting, the Company intends to file a Form 15 with the SEC to terminate the registration of the Common Stock under Section 12(g) of the Exchange Act, thereby suspending the Company’s Exchange Act reporting obligations.

 

A copy of the press release announcing the matters summarized above is filed as Exhibit 99.1 hereto and is incorporated herein by reference.

 

Item 8.01 Other Events

 

On March 7, 2024, the Company issued a press release regarding the matters disclosed in Item 3.01 above. A copy of the press release is furnished herewith as Exhibit 99.1 and is incorporated herein by reference.

 

Item 9.01 Financial Statements and Exhibits.

 

Exhibit

No.

Description

99.1

Press Release of Cyteir Therapeutics, Inc. dated March 7, 2024

104

Cover Page Interactive Data File (embedded within the inline XBRL document)

 

 

 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

 

 

CYTEIR THERAPEUTICS, INC.

 

 

 

 

Date:

March 7, 2024

By:

/s/ David Gaiero

 

 

 

Name: David Gaiero
Title: Chief Financial Officer and Treasurer

 

 EX-99.1 2 cyt-ex99_1.htm EX-99.1 EX-99.1

Exhibit 99.1

Cyteir Announces Timeline for Voluntarily Delisting from Nasdaq

LEXINGTON, MA— March 7, 2024 — Cyteir Therapeutics, Inc. (“Cyteir”) (Nasdaq: CYT) today announced that it has formally notified The Nasdaq Stock Market (“Nasdaq”) of its intent to delist the Company’s common stock from the Nasdaq Global Select Market. Cyteir expects to file a Form 25 (Notification of Removal from Listing) with the Securities and Exchange Commission (the “SEC”) relating to the voluntary delisting of its common stock on or about March 18, 2024 and has requested that the trading of the Common Stock on Nasdaq be suspended effective before the market opens on the same day. Cyteir does not expect that a trading market will develop for its common stock following suspension of trading on Nasdaq. Cyteir intends to file a certificate of dissolution with the Delaware Secretary of State on or about March 20, 2024 and close its stock transfer books at the close of business on this date. The official delisting of Cyteir’s common stock will be effective on or about March 28, 2024, ten days after the filing of the Form 25.

Cyteir also intends to file a Form 15 with the SEC as soon as practicable following the effectiveness of the delisting to indefinitely suspend its reporting obligations under the Securities Exchange Act of 1934, as amended.

The voluntary delisting and deregistration are part of Cyteir’s Plan of Complete Liquidation and Dissolution previously approved by Cyteir’s board of directors and by Cyteir’s stockholders at a special meeting held on November 16, 2023. Cyteir’s board of directors considered a number of factors in determining to delist and deregister its common stock, including the costs and expenses associated with being a publicly traded company, the auditing, legal and other costs associated with continuing to make SEC filings, and the burdens placed on Cyteir’s management to comply with the continued listing and reporting requirements, all in light of Cyteir’s planned dissolution and liquidation.

Forward-Looking Statements

This press release contains “forward-looking statements,” including with respect to the timing of Cyteir’s planned dissolution and liquidation. The words ”believe,” “may,” “will,” “estimate,” “continue,” “anticipate,” “intend,” “expect,” “should,” “could,” “target,” “predict,” “seek” and similar expressions are intended to identify forward-looking statements. All statements other than statements of historical facts contained in this press release are forward-looking statements.

These forward-looking statements are subject to a number of risks, uncertainties and assumptions, which could cause actual results to differ materially from those contained in or implied by the forward-looking statements, including the risks and uncertainties identified under the heading “Risk Factors” in Cyteir’s definitive proxy statement filed with the Securities and Exchange Commission on October 12, 2023.

The forward-looking statements contained in this press release are based on management's current views, plans, estimates, assumptions, and projections with respect to future events, and, except to the extent required by law, Cyteir does not undertake and specifically disclaims any obligation to update any forward-looking statements.

EX-101.SCH 3 cyt-20240307.xsd XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT 100000 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink Pre Commencement Issuer Tender Offer Entity Address, State or Province Trading Symbol Soliciting Material Entity Address, City or Town Written Communications Entity Central Index Key CIK Entity Tax Identification Number Entity Registrant Name Registrant Name Entity Ex Transition Period Document Period End Date Period End Date Entity Address, Postal Zip Code Entity Incorporation State Country Code Local Phone Number City Area Code Pre Commencement Tender Offer Cover [Abstract] Cover Security Exchange Name Entity Emerging Growth Company Amendment Flag Amendment Securities Act File Number Entity Address, Address Line Two Entity Address, Address Line One Security 12b Title Document Type Document Type XML 4 R1.htm IDEA: XBRL DOCUMENT v3.24.0.1
Document and Entity Information
Mar. 07, 2024
Cover [Abstract]  
Amendment Flag false
Entity Central Index Key 0001662244
Document Type 8-K
Document Period End Date Mar. 07, 2024
Entity Registrant Name Cyteir Therapeutics, Inc.
Entity Incorporation State Country Code DE
Securities Act File Number 001-40499
Entity Tax Identification Number 45-5429901
Entity Address, Address Line One P.O. Box 80084
Entity Address, City or Town Stoneham
Entity Address, State or Province MA
Entity Address, Postal Zip Code 02180
City Area Code 857
Local Phone Number 285-4140
Written Communications false
Soliciting Material false
Pre Commencement Tender Offer false
Pre Commencement Issuer Tender Offer false
Security 12b Title Common Stock, $0.001 par value per share
Trading Symbol CYT
Security Exchange Name NASDAQ
Entity Emerging Growth Company true
Entity Ex Transition Period false
EXCEL 6 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx M4$L#!!0 ( /F#9U@'04UB@0 +$ 0 9&]C4')O<',O87!P+GAM M;$V./0L",1!$_\IQO;=!P4)B0-!2L+(/>QLOD&1#LD)^OCG!CVX>;QA&WPIG M*N*I#BV&5(_C(I(/ !47BK9.7:=N')=HI6-Y #OGDK7A.YNJQ<&4GPZ4A!0W_J=0U[R;UEA_6\#MI7E!+ P04 M " #Y@V=8^FEC@^\ K @ $0 &1O8U!R;W!S+V-O&ULS9+! M:L,P#(9?9?B>R$G*"B;U9:6G#08K;.QF9+4UBQ-C:R1]^R59FS*V!]C1TN]/ MGT U!H5=I.?8!8KL*-T-OFF3PK 1)^:@ !*>R)N4CXEV;!ZZZ V/SWB$8/## M' E**>_!$QMKV, $S,)"%+JVJ#"2X2Y>\!87?/B,S0RS"-20IY83%'D!0D\3 MPWEH:K@!)AA3].F[0'8ASM4_L7,'Q"4Y)+>D^K[/^VK.C3L4\/;T^#*OF[DV ML6F1QE_)*3X'VHCKY-?J8;O?"5W*&UL[5I;<]HX%'[OK]!X9_9M"\8V@;:T$W-I=MNTF83M M3A^%$5B-;'EDD81_OTV23;J;/ 0LZ?O.14?GZ#AY\^XN8NB&B)3R M> +]O6N[!3+ MUES@6QHO(];JM-O=5H1I;*$81V1@?5XL:$#05%%:;U\@M.4?,_@5RU2-9:,! M$U=!)KF(M/+Y;,7\VMX^9<_I.ATR@6XP&U@@?\YOI^1.6HCA5,+$P&IG/U9K MQ]'22(""R7V4!;I)]J/3%0@R#3LZG5C.=GSVQ.V?C,K:=#1M&N#C\7@XMLO2 MBW A(5M>5 TR M6'!VULS2 Y9>*?IUE!K9';O=05SP6.XYB1'^QL4$UFG2&98T1G*=D 4. #?$ MT4Q0?*]!MHK@PI+27)#6SRFU4!H(FLB!]4>"(<7K;YH] M5Z%82=J$^!!&&N*<<^9ST6S[!Z5&T?95O-RCEU@5 9<8WS2J-2S%UGB5P/&M MG#P=$Q+-E L&08:7)"82J3E^34@3_BNEVOZKR2.FJW"$2M"/F(9 M-AIRM1:!MG&IA&!:$L;1>$[2M!'\6:PUDSY@R.S-D77.UI$.$9)>-T(^8LZ+ MD!&_'H8X2IKMHG%8!/V>7L-)P>B"RV;]N'Z&U3-L+([W1]072N0/)J<_Z3(T M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+ M.7\N?<^E[[GT/:'2MSAD6R4)RU3393>* M$IY"&V[I4_5*E=?EK[DHN#Q;Y.FOH70^+,_Y/%_GM,T+,T.WF)&Y M"M-2D&_#^>G%>!KB.=D$N7V85VWGV-'1^^?!4;"C[SR6'<>(\J(A[J&&F,_# M0X=Y>U^89Y7&4#04;6RL)"Q&MV"XU_$L%.!D8"V@!X.O40+R4E5@,5O& RN0 MHGQ,C$7H<.>77%_CT9+CVZ9EM6ZO*7<9;2)2.<)IF!-GJ\K>9;'!51W/55OR ML+YJ/;053L_^6:W(GPP13A8+$DACE!>F2J+S&5.^YRM)Q%4XOT4SMA*7&+SC MYL=Q3E.X$G:V#P(RN;LYJ7IE,6>F\M\M# DL6XA9$N)-7>W5YYNTB42%(JP# 4A M%W+C[^^3:G>,U_HL@6V$5#)DU1?*0XG!/3-R0]A4)?.NVB8+A=OB5,V[&KXF M8$O#>FZ=+2?_VU[4/;07/4;SHYG@'K.' MYA,L0Z1^P7V*BH 1JV*^NJ]/^26<.[1[\8$@F_S6VZ3VW> ,?-2K6J5D*Q$_ M2P=\'Y(&8XQ;]#1?CQ1BK::QK<;:,0QY@%CS#*%F.-^'19H:,]6+K#F-"F]! MU4#E/]O4#6CV#30,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04 M" #Y@V=8"TO'GFT$ L$0 & 'AL+W=O,HT6,K-":]ZW:U'T+,=4>FD. O M:ZEB;K"I-EV=*N!!$11'7=>V^]V8B\2:C(I[GBD^W*9SW;8GZF MC8R/P4@0BZ3\YOMC(DX#G#,![C' +;C+%Q64#]SPR4C)'5/YTZB67Q1=+:(1 M3B3YJ"R,PE\%QIG)@_0S3+)A/ G88V*$.;"GI!QMS-JH:_ E^:-=_RAX7PJZ M9P2?N>HP^_:*N;;K_3>\BVP5H%L!NH7>S1F]F=R"8G]-5]HH',*_FXA*!:]9 M(:_K.YUR'\86%JX&M05K\M,/3M_^F>"[J?AN*/7)%+,7%!G\%/%-$QT=O^:1 M!H+#JS@\4NCAJ]78?5(L:J^EH<4 MFECH\,'U%P*B7T'T+X.8@Q(RK_. X6QIY*&5BNHNRKNMOF\KMMM+QNT--B*O M<(1\X7$C&:TS.Q@0BBU#4#R%S A?7V$5^!V"<5 Q#BYA1#6I4JD*9V +@QED M,YEAP6'=R: 1FA9^>"3HAA7=D!19@)\I801H-O5Q&HH(V$L6KT U =%:6/K7 MGNT-AP278]?>:E^2MR7?LZ< ZT^LA5\F[SQ?BZ37N^YY[G!H.Q3AB?L[EQ!. M@P"=$0OF>,&^XG/L-6D>>UP^[EG@UL>T#-$*=> AS2P;^CG.4MB<4N M=\TK%"VW,#*!D,<46VW_#NW?_V&AS:T;]* M'W,R#[$DJ%E)B[B#WK7G>&1JZ@7!H9W\&YJ9@003$\=92O"HD8=6:>6I'=^A;7JNH$@/X/PJ=Q>X"<-MXNMZ M?6;\:+TV,K>V?)?VY^_(GK3.D*P-L$6V%;!V?)>VY^-J>6".NV)+8:+&R=PV )(__V*_6AW<-UD*5=LRZ,,6(H]U2%7)/') 8"VZZ7B05YYBT.\DHUU MUR(P^V-)@=16[]*V7*7N<>^'/-G V:U:B]#+=/$P_95BJCW>OM=GB7-N@/LCW# <13?+'O*3?@C5BTVMD)T#TY M^^;_(^ .'1.A601K%+([MZBKRJ-YV3 R+8[#*VGP<%U&PO9KEMWDOSAR+DCO9*ZW="C<\W[)&D/1ZY8 M^\XT7'ND,E8QYU5;)VUC.2M;<%(R6=[<9(EB0M-BK3MUIUQ+#J;3;D-O:%*L M*Z//EI0&@U_*%">/3&[HEDFQMV)8RY20IV!>@N%@I+'$>2I\0Q=@:9\"O @: ML!SC**&-!6,2,H3O_;C\&3!IK5>%E#/!)0V&8MTPY[C5=UX9%@_&%Q 9Y=VI M\0QKRTZ+Y2T].PP_/LG>V)+;.'36-/+T08I:*Q[V_LL)BS6; M_,C16/'DL\&D'+R!6TH>N77B<&GY85FSX[V;IJFO<,[+?Y#SGZUSS36W3%Z2 M]J/_-U?Y+8R3\?1<'-&K SI;"5R$&_H5[E=YYD#VG9!.Z%$[BK+D^L4Y]>$= MV_L+_"J^7U_RBG72[69P0\_R%UZ*3N7SJGNHR[CJ+'^&^VB1S;>PSR5TR7M> M;D?5UOM!)%[P6<<'')XC=\,31S"?@,41P+ \& /,)WAA>?ZG_:S0_00,X[:* M(BO49X7Z!*\8LAT^6)ZX3^Z?^$[S/$VS#*OH=AMEL,7JEF7P%X^&<0,/+ ]D M>ENM\6[C$_+Z'& ]?6U"L)WBDXCM%*\U(/&Z@4>>Q[N-Y0$/K O8[$#^>!Z8 MJ;A/FD)7,6[8"<:1/,<0F,7XC&894IT,/O'^8* \^>Q\ETWLJ.?]74_P$4$L#!!0 ( /F#9UB7BKL

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end XML 7 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 8 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 10 FilingSummary.xml IDEA: XBRL DOCUMENT 3.24.0.1 html 1 23 1 false 0 0 false 0 false false R1.htm 100000 - Document - Document and Entity Information Sheet http://cyteir.com/20240307/taxonomy/role/DocumentDocumentAndEntityInformation Document and Entity Information Cover 1 false false All Reports Book All Reports cyt-20240307.htm cyt-20240307.xsd http://xbrl.sec.gov/dei/2023 false false JSON 12 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "cyt-20240307.htm": { "nsprefix": "cyt", "nsuri": "http://cyteir.com/20240307", "dts": { "inline": { "local": [ "cyt-20240307.htm" ] }, "schema": { "local": [ "cyt-20240307.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd" ] } }, "keyStandard": 23, "keyCustom": 0, "axisStandard": 0, "axisCustom": 0, "memberStandard": 0, "memberCustom": 0, "hidden": { "total": 2, "http://xbrl.sec.gov/dei/2023": 2 }, "contextCount": 1, "entityCount": 1, "segmentCount": 0, "elementCount": 25, "unitCount": 0, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2023": 23 }, "report": { "R1": { "role": "http://cyteir.com/20240307/taxonomy/role/DocumentDocumentAndEntityInformation", "longName": "100000 - Document - Document and Entity Information", "shortName": "Document and Entity Information", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "C_0108114d-2a45-401b-9928-01ee732f0650", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "cyt-20240307.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_0108114d-2a45-401b-9928-01ee732f0650", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "cyt-20240307.htm", "first": true, "unique": true } } }, "tag": { "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentFlag", "presentation": [ "http://cyteir.com/20240307/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Amendment Flag", "terseLabel": "Amendment", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CityAreaCode", "presentation": [ "http://cyteir.com/20240307/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "label": "Cover [Abstract]", "terseLabel": "Cover", "documentation": "Cover page." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodEndDate", "presentation": [ "http://cyteir.com/20240307/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Period End Date", "terseLabel": "Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentType", "presentation": [ "http://cyteir.com/20240307/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Type", "terseLabel": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine1", "presentation": [ "http://cyteir.com/20240307/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine2": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine2", "presentation": [ "http://cyteir.com/20240307/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Two", "documentation": "Address Line 2 such as Street or Suite number" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCityOrTown", "presentation": [ "http://cyteir.com/20240307/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://cyteir.com/20240307/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://cyteir.com/20240307/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCentralIndexKey", "presentation": [ "http://cyteir.com/20240307/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Central Index Key", "terseLabel": "CIK", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r1" ] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://cyteir.com/20240307/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r1" ] }, "dei_EntityExTransitionPeriod": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityExTransitionPeriod", "presentation": [ "http://cyteir.com/20240307/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Ex Transition Period", "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards." } } }, "auth_ref": [ "r7" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFileNumber", "presentation": [ "http://cyteir.com/20240307/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Securities Act File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://cyteir.com/20240307/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Incorporation State Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityRegistrantName", "presentation": [ "http://cyteir.com/20240307/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Registrant Name", "terseLabel": "Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r1" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://cyteir.com/20240307/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r1" ] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LocalPhoneNumber", "presentation": [ "http://cyteir.com/20240307/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://cyteir.com/20240307/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Pre Commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r3" ] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementTenderOffer", "presentation": [ "http://cyteir.com/20240307/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Pre Commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r4" ] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12bTitle", "presentation": [ "http://cyteir.com/20240307/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Security 12b Title", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r0" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityExchangeName", "presentation": [ "http://cyteir.com/20240307/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r2" ] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SolicitingMaterial", "presentation": [ "http://cyteir.com/20240307/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r5" ] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "TradingSymbol", "presentation": [ "http://cyteir.com/20240307/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "WrittenCommunications", "presentation": [ "http://cyteir.com/20240307/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r6" ] } } } }, "std_ref": { "r0": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r1": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r2": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r3": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r4": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r5": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Section": "14a", "Number": "240", "Subsection": "12" }, "r6": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" }, "r7": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "7A", "Section": "B", "Subsection": "2" } } } ZIP 13 0000950170-24-028044-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0000950170-24-028044-xbrl.zip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end XML 14 cyt-20240307_htm.xml IDEA: XBRL DOCUMENT 0001662244 2024-03-07 2024-03-07 0001662244 false 8-K 2024-03-07 Cyteir Therapeutics, Inc. DE 001-40499 45-5429901 P.O. Box 80084 Stoneham MA 02180 857 285-4140 false false false false Common Stock, $0.001 par value per share CYT NASDAQ true false